Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+ NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial

              Author:Pittock, Sean   Barnett, Michael   Bennett, Jeffrey   Berthele, Achim   De Seze, Jerome   Levy, Michael   Nakashima, Ichiro   Oreja-Guevara, Celia   Palace, Jacqueline   Paul, Friedemann   Pozzilli, Carlo   Mashhoon, Yasmin   Allen, Kerstin   Parks, Becky   Kim, Ho Jin   

              Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

              Topic:Autoimmune Neurology  

              Program Number:S32.003  

              Author Institution:Mayo Clinic, Rochester, MN  University of Sydney, Camperdown, Australia  University of Colorado, Aurora, CO  School of Medicine, Technical University Munich, Munich, Germany  Strasbourg University Hospital Center, Strasbourg, France  Massachusetts General Hospital/Harvard Medical School, Boston, MA  Tohoku Medical and Pharmaceutical University, Sendai, Japan  San Carlos Clinical Hospital and Complutense University of Madrid, Madrid, Spain  John Radcliffe Hospital, Oxford, United Kingdom  Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany  Sapienza University, Rome, Italy  Alexion, AstraZeneca Rare Disease, Boston, MA  National Cancer Center, Goyang, Korea, Republic of